By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


TapImmune Inc. 

2815 Eastlake Avenue East
Suite 300
Seattle  Washington  98102  U.S.A.
Phone: 866-359-7541 Fax: n/a




Company News
Immuno-Oncology Company, TapImmune Inc. (TPIV), Moves Corporate Headquarters To Jacksonville Florida 11/5/2015 6:49:14 AM
TapImmune Inc. (TPIV) To Present At Dawson James Small Cap Growth Conference In Florida On October 15, 2015 10/13/2015 10:17:37 AM
TapImmune Inc. (TPIV) To Present At Aegis Capital 2015 Growth Conference In Las Vegas On October 9, 2015 10/7/2015 10:08:31 AM
TapImmune Inc. (TPIV) Vaccine To Be Studied In A $13.3 Million U.S. Department Of Defense Grant To Mayo Clinic For Phase II Clinical Trial In Triple Negative Breast Cancer 9/15/2015 8:24:13 AM
TapImmune Inc. (TPIV) To Provide Update On And Confirmation Of Phase II Clinic Trial Initiation 9/10/2015 11:45:35 AM
TapImmune Inc. (TPIV) To Present At The SeeThruEquities Fall 9/8/2015 10:15:05 AM
TapImmune Inc. (TPIV) To Present At 17th Annual Rodman & Renshaw Healthcare Conference 9/2/2015 9:04:19 AM
TapImmune Inc. (TPIV) Completes Transfer of IND From The Mayo Clinic 8/18/2015 6:48:46 AM
TapImmune Inc. (TPIV) Appoints John N. Bonfiglio, Ph.D., To Its Board Of Directors 7/30/2015 11:57:25 AM
TapImmune Inc. (TPIV) Announces Finalization Of License Agreement With Mayo Clinic To Commercialize A Folate Receptor Alpha Vaccine For Multiple Cancer Indications 7/27/2015 11:09:32 AM